Molquant is defining the emerging field of Applied Translational Genomics.
Using biologically-directed statistical approaches, Molquant is building a new framework to interpret genomic data. Our tools reveal relationships among functionally-related genes, connecting genomic variation to relevant biology. Linking genotypes and phenotypes to biology leads to new insights that enable novel translational approaches to human health and disease.
To date, Molquant has discovered biomarkers, novel gene networks, and elucidated biology for these complex diseases:
Murray O. Robinson, Ph.D.
With more than 20 years experience exploring the molecular genetics of cancer to drive drug discovery and development, molecular biologist Dr. Robinson is a pioneer in the effort to decode our genes.